Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study

Abstract Background Research has revealed that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) may prevent cancers such as hepatocellular carcinoma (HCC). The comparative chemopreventive effects of ACEIs and ARBs in high-risk populations with hepatitis B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cheng-Maw Ho, Chih-Hsin Lee, Ming-Chia Lee, Jun-Fu Zhang, Jann-Yuan Wang, Rey-Heng Hu, Po-Huang Lee
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2018-04-01
Colecção:BMC Cancer
Assuntos:
Hepatocellular carcinoma
Chemoprevention
High-risk cohort
Comparative effectiveness
Angiotensin-converting enzyme inhibitors
Angiotensin II receptor blockers
Acesso em linha:http://link.springer.com/article/10.1186/s12885-018-4292-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados